We don't know whether the most recent response to this request contains information or not – if you are Oliver Caswell please sign in and let everyone know.

Dabrafenib + Trametinib in cancer treatment

We're waiting for Oliver Caswell to read recent responses and update the status.

Dear Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust,

I would be grateful if you could please answer these questions relating to the usage of Dabrafenib + Trametinib in cancer treatment.

A) Over the previous 6 months, how many patients for the following diseases have been treated with a combination of Dabrafenib + Trametinib:
i) Metastatic Melanoma
ii) Adjuvant Melanoma
iii) BRAF mutated Lung Cancer

Many thanks for taking the time to answer these questions.

Yours faithfully,

Oliver Caswell

TINGLE, Adam (DONCASTER AND BASSETLAW TEACHING HOSPITALS NHS FOUNDATION TRUST), Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust

I am currently out of the office on paternity leave, returning 24 April.
For urgent enquiries relating to communications please contact 01302
644244 or email [email address] or [email address].

show quoted sections

WRAITH, Diane (DONCASTER AND BASSETLAW TEACHING HOSPITALS NHS FOUNDATION TRUST), Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust

1 Attachment

Dear Oliver, 

 

Please find attached our response to your Freedom of Information request.

 

Kind regards,

 

Diane Wraith

Admin Assistant

Communications and Engagement

Doncaster and Bassetlaw Teaching Hospitals

NHS Foundation Trust

T:01302 644246

E: [1][email address]

 

show quoted sections

We don't know whether the most recent response to this request contains information or not – if you are Oliver Caswell please sign in and let everyone know.